Insights

These three Chinese robotics firms are tapping public markets to bankroll their next phase of international growth.

With rising exports, factory rollouts, and new listings, Chinese automakers are redefining what it means to go global.

As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets.

Once the go-to for in-vehicle chips, Nvidia is facing defections from Chinese carmakers amid delays, performance setbacks, and cultural disconnect.

From EVs to Meituan food deliveries and Mixue bubble tea, newcomers are edging out rivals.

Former chart toppers like Maoxiang and Talkie now see sharp user declines, weak monetization, and mounting regulatory pressure.

But tensions with the US still cast a cloud over overseas expansion ambitions.

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.